Management of treatment‐resistant nocturnal enuresis
Nocturnal enuresis is defined as intermittent urinary incontinence during sleep in children 5 years of age and older, occurring at least once a month for at least 3 months. In Japan, pediatricians who do not specialize in nocturnal enuresis have become more proactive in treating the condition since...
Gespeichert in:
Veröffentlicht in: | Pediatrics international 2023-01, Vol.65 (1), p.e15573-n/a |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 1 |
container_start_page | e15573 |
container_title | Pediatrics international |
container_volume | 65 |
creator | Tsuji, Shoji Kaneko, Kazunari |
description | Nocturnal enuresis is defined as intermittent urinary incontinence during sleep in children 5 years of age and older, occurring at least once a month for at least 3 months. In Japan, pediatricians who do not specialize in nocturnal enuresis have become more proactive in treating the condition since 2016, when the guidelines for treating it were revised for the first time in 12 years. For monosymptomatic nocturnal enuresis, the first step is lifestyle guidance, with a focus on the restriction of fluid intake at night; however, if lifestyle guidance does not decrease the frequency of nocturnal enuresis, aggressive treatment should be added. The first choice of aggressive treatment is oral desmopressin, an antidiuretic hormone preparation, or alarm therapy. However, there remain patients whose wet nights do not decrease with oral desmopressin or alarm therapy. In such cases, it is necessary to reconfirm the method of desmopressin administration and check for factors that may decrease the efficacy of desmopressin. If alarm therapy does not increase the number of dry nights, it is possible that the patient is fundamentally unsuitable for alarm therapy. If dry nights do not increase with oral desmopressin or alarm therapy, the next treatment strategy should be considered immediately to keep the patient motivated for treatment. |
doi_str_mv | 10.1111/ped.15573 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2836297233</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2906279021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3773-641a303138c41b1b415f2df95c77c57f8b6164fed9a3b3d72f86108ca319d6783</originalsourceid><addsrcrecordid>eNp10MtKAzEUBuAgiq3VhS8gBTe6mDbJySSZpdR6AUUXCu5CJpPIlLnUyQzSnY_gM_okpp12I5hNkpOPn_AjdErwhIQ1XdpsQuJYwB4aEsZoRDF-2w9noDKSmIsBOvJ-gTGWQrJDNADBqJQ0HiL-qCv9bktbtePajdvG6nZ9-fn6bqzPfavDQ1WbtmsqXYxt1W3Gx-jA6cLbk-0-Qq8385fZXfTwdHs_u3qIDAgBEWdEAwYC0jCSkpSR2NHMJbERwsTCyZQTzpzNEg0pZII6yQmWRgNJMi4kjNBFn7ts6o_O-laVuTe2KHRl684rKoHTRFCAQM__0EW9-XRQCeZUJJiSoC57ZZra-8Y6tWzyUjcrRbBal6lCmWpTZrBn28QuLcN0J3ftBTDtwWde2NX_Sep5ft1H_gLq631I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2906279021</pqid></control><display><type>article</type><title>Management of treatment‐resistant nocturnal enuresis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Tsuji, Shoji ; Kaneko, Kazunari</creator><creatorcontrib>Tsuji, Shoji ; Kaneko, Kazunari</creatorcontrib><description>Nocturnal enuresis is defined as intermittent urinary incontinence during sleep in children 5 years of age and older, occurring at least once a month for at least 3 months. In Japan, pediatricians who do not specialize in nocturnal enuresis have become more proactive in treating the condition since 2016, when the guidelines for treating it were revised for the first time in 12 years. For monosymptomatic nocturnal enuresis, the first step is lifestyle guidance, with a focus on the restriction of fluid intake at night; however, if lifestyle guidance does not decrease the frequency of nocturnal enuresis, aggressive treatment should be added. The first choice of aggressive treatment is oral desmopressin, an antidiuretic hormone preparation, or alarm therapy. However, there remain patients whose wet nights do not decrease with oral desmopressin or alarm therapy. In such cases, it is necessary to reconfirm the method of desmopressin administration and check for factors that may decrease the efficacy of desmopressin. If alarm therapy does not increase the number of dry nights, it is possible that the patient is fundamentally unsuitable for alarm therapy. If dry nights do not increase with oral desmopressin or alarm therapy, the next treatment strategy should be considered immediately to keep the patient motivated for treatment.</description><identifier>ISSN: 1328-8067</identifier><identifier>EISSN: 1442-200X</identifier><identifier>DOI: 10.1111/ped.15573</identifier><identifier>PMID: 37428825</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Adrenergic beta-3 Receptor Agonists ; anticholinergic ; Antidiuretic Agents - therapeutic use ; Antidiuretics ; beta‐3 adrenergic agonist ; Cholinergic Antagonists ; Deamino Arginine Vasopressin - therapeutic use ; Desmopressin ; Enuresis ; Fluid intake ; Humans ; Nighttime ; Nocturnal Enuresis - diagnosis ; Nocturnal Enuresis - drug therapy ; Patients ; Pediatrics ; treatment resistant ; tricyclic antidepressant ; Urinary incontinence</subject><ispartof>Pediatrics international, 2023-01, Vol.65 (1), p.e15573-n/a</ispartof><rights>2023 Japan Pediatric Society.</rights><rights>2023 Japan Pediatric Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3773-641a303138c41b1b415f2df95c77c57f8b6164fed9a3b3d72f86108ca319d6783</citedby><cites>FETCH-LOGICAL-c3773-641a303138c41b1b415f2df95c77c57f8b6164fed9a3b3d72f86108ca319d6783</cites><orcidid>0000-0003-3607-8355 ; 0000-0002-8215-0832</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fped.15573$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fped.15573$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37428825$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsuji, Shoji</creatorcontrib><creatorcontrib>Kaneko, Kazunari</creatorcontrib><title>Management of treatment‐resistant nocturnal enuresis</title><title>Pediatrics international</title><addtitle>Pediatr Int</addtitle><description>Nocturnal enuresis is defined as intermittent urinary incontinence during sleep in children 5 years of age and older, occurring at least once a month for at least 3 months. In Japan, pediatricians who do not specialize in nocturnal enuresis have become more proactive in treating the condition since 2016, when the guidelines for treating it were revised for the first time in 12 years. For monosymptomatic nocturnal enuresis, the first step is lifestyle guidance, with a focus on the restriction of fluid intake at night; however, if lifestyle guidance does not decrease the frequency of nocturnal enuresis, aggressive treatment should be added. The first choice of aggressive treatment is oral desmopressin, an antidiuretic hormone preparation, or alarm therapy. However, there remain patients whose wet nights do not decrease with oral desmopressin or alarm therapy. In such cases, it is necessary to reconfirm the method of desmopressin administration and check for factors that may decrease the efficacy of desmopressin. If alarm therapy does not increase the number of dry nights, it is possible that the patient is fundamentally unsuitable for alarm therapy. If dry nights do not increase with oral desmopressin or alarm therapy, the next treatment strategy should be considered immediately to keep the patient motivated for treatment.</description><subject>Adrenergic beta-3 Receptor Agonists</subject><subject>anticholinergic</subject><subject>Antidiuretic Agents - therapeutic use</subject><subject>Antidiuretics</subject><subject>beta‐3 adrenergic agonist</subject><subject>Cholinergic Antagonists</subject><subject>Deamino Arginine Vasopressin - therapeutic use</subject><subject>Desmopressin</subject><subject>Enuresis</subject><subject>Fluid intake</subject><subject>Humans</subject><subject>Nighttime</subject><subject>Nocturnal Enuresis - diagnosis</subject><subject>Nocturnal Enuresis - drug therapy</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>treatment resistant</subject><subject>tricyclic antidepressant</subject><subject>Urinary incontinence</subject><issn>1328-8067</issn><issn>1442-200X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MtKAzEUBuAgiq3VhS8gBTe6mDbJySSZpdR6AUUXCu5CJpPIlLnUyQzSnY_gM_okpp12I5hNkpOPn_AjdErwhIQ1XdpsQuJYwB4aEsZoRDF-2w9noDKSmIsBOvJ-gTGWQrJDNADBqJQ0HiL-qCv9bktbtePajdvG6nZ9-fn6bqzPfavDQ1WbtmsqXYxt1W3Gx-jA6cLbk-0-Qq8385fZXfTwdHs_u3qIDAgBEWdEAwYC0jCSkpSR2NHMJbERwsTCyZQTzpzNEg0pZII6yQmWRgNJMi4kjNBFn7ts6o_O-laVuTe2KHRl684rKoHTRFCAQM__0EW9-XRQCeZUJJiSoC57ZZra-8Y6tWzyUjcrRbBal6lCmWpTZrBn28QuLcN0J3ftBTDtwWde2NX_Sep5ft1H_gLq631I</recordid><startdate>202301</startdate><enddate>202301</enddate><creator>Tsuji, Shoji</creator><creator>Kaneko, Kazunari</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3607-8355</orcidid><orcidid>https://orcid.org/0000-0002-8215-0832</orcidid></search><sort><creationdate>202301</creationdate><title>Management of treatment‐resistant nocturnal enuresis</title><author>Tsuji, Shoji ; Kaneko, Kazunari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3773-641a303138c41b1b415f2df95c77c57f8b6164fed9a3b3d72f86108ca319d6783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adrenergic beta-3 Receptor Agonists</topic><topic>anticholinergic</topic><topic>Antidiuretic Agents - therapeutic use</topic><topic>Antidiuretics</topic><topic>beta‐3 adrenergic agonist</topic><topic>Cholinergic Antagonists</topic><topic>Deamino Arginine Vasopressin - therapeutic use</topic><topic>Desmopressin</topic><topic>Enuresis</topic><topic>Fluid intake</topic><topic>Humans</topic><topic>Nighttime</topic><topic>Nocturnal Enuresis - diagnosis</topic><topic>Nocturnal Enuresis - drug therapy</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>treatment resistant</topic><topic>tricyclic antidepressant</topic><topic>Urinary incontinence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsuji, Shoji</creatorcontrib><creatorcontrib>Kaneko, Kazunari</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsuji, Shoji</au><au>Kaneko, Kazunari</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of treatment‐resistant nocturnal enuresis</atitle><jtitle>Pediatrics international</jtitle><addtitle>Pediatr Int</addtitle><date>2023-01</date><risdate>2023</risdate><volume>65</volume><issue>1</issue><spage>e15573</spage><epage>n/a</epage><pages>e15573-n/a</pages><issn>1328-8067</issn><eissn>1442-200X</eissn><abstract>Nocturnal enuresis is defined as intermittent urinary incontinence during sleep in children 5 years of age and older, occurring at least once a month for at least 3 months. In Japan, pediatricians who do not specialize in nocturnal enuresis have become more proactive in treating the condition since 2016, when the guidelines for treating it were revised for the first time in 12 years. For monosymptomatic nocturnal enuresis, the first step is lifestyle guidance, with a focus on the restriction of fluid intake at night; however, if lifestyle guidance does not decrease the frequency of nocturnal enuresis, aggressive treatment should be added. The first choice of aggressive treatment is oral desmopressin, an antidiuretic hormone preparation, or alarm therapy. However, there remain patients whose wet nights do not decrease with oral desmopressin or alarm therapy. In such cases, it is necessary to reconfirm the method of desmopressin administration and check for factors that may decrease the efficacy of desmopressin. If alarm therapy does not increase the number of dry nights, it is possible that the patient is fundamentally unsuitable for alarm therapy. If dry nights do not increase with oral desmopressin or alarm therapy, the next treatment strategy should be considered immediately to keep the patient motivated for treatment.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>37428825</pmid><doi>10.1111/ped.15573</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-3607-8355</orcidid><orcidid>https://orcid.org/0000-0002-8215-0832</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1328-8067 |
ispartof | Pediatrics international, 2023-01, Vol.65 (1), p.e15573-n/a |
issn | 1328-8067 1442-200X |
language | eng |
recordid | cdi_proquest_miscellaneous_2836297233 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adrenergic beta-3 Receptor Agonists anticholinergic Antidiuretic Agents - therapeutic use Antidiuretics beta‐3 adrenergic agonist Cholinergic Antagonists Deamino Arginine Vasopressin - therapeutic use Desmopressin Enuresis Fluid intake Humans Nighttime Nocturnal Enuresis - diagnosis Nocturnal Enuresis - drug therapy Patients Pediatrics treatment resistant tricyclic antidepressant Urinary incontinence |
title | Management of treatment‐resistant nocturnal enuresis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T04%3A28%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20treatment%E2%80%90resistant%20nocturnal%20enuresis&rft.jtitle=Pediatrics%20international&rft.au=Tsuji,%20Shoji&rft.date=2023-01&rft.volume=65&rft.issue=1&rft.spage=e15573&rft.epage=n/a&rft.pages=e15573-n/a&rft.issn=1328-8067&rft.eissn=1442-200X&rft_id=info:doi/10.1111/ped.15573&rft_dat=%3Cproquest_cross%3E2906279021%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2906279021&rft_id=info:pmid/37428825&rfr_iscdi=true |